CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE

This adverse event was reported 21 times

These drugs are most commonly taken by patients reporting CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE:

# Drug Count
0 LENALIDOMIDE 11
1 MELPHALAN 11
2 MELPHALAN HYDROCHLORIDE 11
3 POMALIDOMIDE 10
4 CILTACABTAGENE AUTOLEUCEL 6
5 IDECABTAGENE VICLEUCEL 5
6 OLAPARIB 2
7 RITUXIMAB 2
8 AMLODIPINE BESYLATE 1
9 AXICABTAGENE CILOLEUCEL 1
See all common drugs associated with CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE

CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 IDECABTAGENE VICLEUCEL 5 0.0040
1 CILTACABTAGENE AUTOLEUCEL 6 0.0009
2 BREXUCABTAGENE AUTOLEUCEL 1 0.0005
3 MELPHALAN HYDROCHLORIDE 11 0.0004
4 LUSPATERCEPT 1 0.0004
5 AXICABTAGENE CILOLEUCEL 1 0.0001
6 POMALIDOMIDE 10 0.0001
7 OLAPARIB 2 0.0001
8 FAM-TRASTUZUMAB DERUXTECAN-NXKI 1 0.0001
9 LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE 1 0.0001
See all drugs enriched for association with CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE